{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,30]],"date-time":"2026-06-30T05:44:11Z","timestamp":1782798251321,"version":"3.54.5"},"reference-count":152,"publisher":"Springer Science and Business Media LLC","license":[{"start":{"date-parts":[[2026,6,30]],"date-time":"2026-06-30T00:00:00Z","timestamp":1782777600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2026,6,30]],"date-time":"2026-06-30T00:00:00Z","timestamp":1782777600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"DOI":"10.13039\/501100006752","name":"Universidade do Porto","doi-asserted-by":"crossref","id":[{"id":"10.13039\/501100006752","id-type":"DOI","asserted-by":"crossref"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["J Thromb Thrombolysis"],"DOI":"10.1007\/s11239-026-03342-z","type":"journal-article","created":{"date-parts":[[2026,6,30]],"date-time":"2026-06-30T03:53:52Z","timestamp":1782791632000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["IGF-1 axis: The signalling bond in cancer-associated thrombosis and cachexia?"],"prefix":"10.1007","author":[{"given":"Mariana Moreira","family":"Pires","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Val\u00e9ria","family":"Tavares","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tiago","family":"Ferreira","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ana Carolina Le\u00e3o","family":"Silva","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"In\u00eas Guerra","family":"de Melo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-3010-8373","authenticated-orcid":false,"given":"Rui","family":"Medeiros","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,6,30]]},"reference":[{"key":"3342_CR1","doi-asserted-by":"publisher","first-page":"646","DOI":"10.1016\/j.cell.2011.02.013","volume":"144","author":"D Hanahan","year":"2011","unstructured":"Hanahan D, Weinberg RA (2011) Hallmarks of cancer: the next generation. Cell 144:646\u2013674","journal-title":"Cell"},{"key":"3342_CR2","doi-asserted-by":"publisher","first-page":"229","DOI":"10.3322\/caac.21834","volume":"74","author":"F Bray","year":"2024","unstructured":"Bray F, Laversanne M, Sung H, Ferlay J, Siegel RL, Soerjomataram I, Jemal A (2024) Global cancer statistics 2022: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries. Cancer J Clin 74:229\u2013263","journal-title":"Cancer J Clin"},{"key":"3342_CR3","doi-asserted-by":"publisher","first-page":"87","DOI":"10.2174\/1568009622666220816120353","volume":"23","author":"S Terracina","year":"2023","unstructured":"Terracina S, Ferraguti G, Petrella C, Bruno SM, Blacon\u00e0 G, Di Certo MG, Minni A, Greco A, Musacchio A, Ralli M (2023) Characteristic hallmarks of aging and the impact on carcinogenesis. Curr Cancer Drug Targets 23:87\u2013102","journal-title":"Curr Cancer Drug Targets"},{"key":"3342_CR4","doi-asserted-by":"publisher","first-page":"693","DOI":"10.1007\/s11010-024-05041-w","volume":"480","author":"K Taunk","year":"2025","unstructured":"Taunk K, Jajula S, Bhavsar PP, Choudhari M, Bhanuse S, Tamhankar A, Naiya T, Kalita B, Rapole S (2025) The prowess of metabolomics in cancer research: current trends, challenges and future perspectives. Mol Cell Biochem 480:693\u2013720","journal-title":"Mol Cell Biochem"},{"key":"3342_CR5","doi-asserted-by":"publisher","first-page":"148","DOI":"10.1158\/jcr.1925.148","volume":"9","author":"O Warburg","year":"1925","unstructured":"Warburg O (1925) The metabolism of carcinoma cells. J Cancer Res 9:148\u2013163","journal-title":"J Cancer Res"},{"key":"3342_CR6","doi-asserted-by":"publisher","first-page":"1029","DOI":"10.1126\/science.1160809","volume":"324","author":"MG Vander Heiden","year":"2009","unstructured":"Vander Heiden MG, Cantley LC, Thompson CB (2009) Understanding the Warburg effect: the metabolic requirements of cell proliferation. Science 324:1029\u20131033","journal-title":"Science"},{"key":"3342_CR7","doi-asserted-by":"publisher","first-page":"1056","DOI":"10.3390\/cells10051056","volume":"10","author":"C Schiliro","year":"2021","unstructured":"Schiliro C, Firestein BL (2021) Mechanisms of metabolic reprogramming in cancer cells supporting enhanced growth and proliferation. Cells 10:1056","journal-title":"Cells"},{"key":"3342_CR8","doi-asserted-by":"publisher","first-page":"409","DOI":"10.3389\/fonc.2020.00409","volume":"10","author":"M L\u00e4sche","year":"2020","unstructured":"L\u00e4sche M, Emons G, Gr\u00fcndker C (2020) Shedding new light on cancer metabolism: a metabolic tightrope between life and death. Front Oncol 10:409","journal-title":"Front Oncol"},{"key":"3342_CR9","doi-asserted-by":"publisher","first-page":"10","DOI":"10.1186\/s40164-024-00482-x","volume":"13","author":"J Yang","year":"2024","unstructured":"Yang J, Shay C, Saba NF, Teng Y (2024) Cancer metabolism and carcinogenesis. Experimental Hematol Oncol 13:10","journal-title":"Experimental Hematol Oncol"},{"key":"3342_CR10","doi-asserted-by":"publisher","first-page":"83","DOI":"10.1016\/j.molmet.2019.08.021","volume":"33","author":"P Kreuzaler","year":"2020","unstructured":"Kreuzaler P, Panina Y, Segal J, Yuneva M (2020) Adapt and conquer: Metabolic flexibility in cancer growth, invasion and evasion. Mol metabolism 33:83\u2013101","journal-title":"Mol metabolism"},{"key":"3342_CR11","first-page":"119","volume":"38","author":"I San-Mill\u00e1n","year":"2017","unstructured":"San-Mill\u00e1n I, Brooks GA (2017) Reexamining cancer metabolism: lactate production for carcinogenesis could be the purpose and explanation of the Warburg Effect. Carcinogenesis 38:119\u2013133","journal-title":"Carcinogenesis"},{"key":"3342_CR12","doi-asserted-by":"publisher","first-page":"2308","DOI":"10.3390\/cells9102308","volume":"9","author":"JH Park","year":"2020","unstructured":"Park JH, Pyun WY, Park HW (2020) Cancer metabolism: phenotype, signaling and therapeutic targets. Cells 9:2308","journal-title":"Cells"},{"key":"3342_CR13","doi-asserted-by":"publisher","first-page":"126","DOI":"10.1186\/s13046-020-01629-4","volume":"39","author":"J Feng","year":"2020","unstructured":"Feng J, Li J, Wu L, Yu Q, Ji J, Wu J, Dai W, Guo C (2020) Emerging roles and the regulation of aerobic glycolysis in hepatocellular carcinoma. J Experimental Clin Cancer Res 39:126","journal-title":"J Experimental Clin Cancer Res"},{"key":"3342_CR14","doi-asserted-by":"publisher","first-page":"138","DOI":"10.1186\/s12943-023-01827-6","volume":"22","author":"A Glaviano","year":"2023","unstructured":"Glaviano A, Foo AS, Lam HY, Yap KC, Jacot W, Jones RH, Eng H, Nair MG, Makvandi P, Geoerger B (2023) PI3K\/AKT\/mTOR signaling transduction pathway and targeted therapies in cancer. Mol Cancer 22:138","journal-title":"Mol Cancer"},{"key":"3342_CR15","doi-asserted-by":"publisher","first-page":"1055589","DOI":"10.3389\/fonc.2022.1055589","volume":"12","author":"H Werner","year":"2022","unstructured":"Werner H, LeRoith D (2022) Hallmarks of cancer: The insulin-like growth factors perspective. Front Oncol 12:1055589","journal-title":"Front Oncol"},{"key":"3342_CR16","doi-asserted-by":"publisher","first-page":"199","DOI":"10.1016\/j.gendis.2022.03.002","volume":"10","author":"P Wang","year":"2023","unstructured":"Wang P, Mak VC, Cheung LW (2023) Drugging IGF-1R in cancer: New insights and emerging opportunities. Genes Dis 10:199\u2013211","journal-title":"Genes Dis"},{"key":"3342_CR17","doi-asserted-by":"publisher","first-page":"103989","DOI":"10.1016\/j.critrevonc.2023.103989","volume":"186","author":"J Liz-Pimenta","year":"2023","unstructured":"Liz-Pimenta J, Tavares V, Neto BV, Santos JM, Guedes CB, Ara\u00fajo A, Khorana AA, Medeiros R (2023) Thrombosis and cachexia in cancer: Two partners in crime? Crit Rev Oncol\/Hematol 186:103989","journal-title":"Crit Rev Oncol\/Hematol"},{"key":"3342_CR18","doi-asserted-by":"publisher","first-page":"1274","DOI":"10.1002\/jcsm.13216","volume":"14","author":"T Shukuya","year":"2023","unstructured":"Shukuya T, Takahashi K, Shintani Y, Miura K, Sekine I, Takayama K, Inoue A, Okamoto I, Kiura K, Kawaguchi T (2023) Epidemiology, risk factors and impact of cachexia on patient outcome: results from the Japanese Lung Cancer Registry Study. J cachexia sarcopenia muscle 14:1274\u20131285","journal-title":"J cachexia sarcopenia muscle"},{"key":"3342_CR19","doi-asserted-by":"publisher","first-page":"610","DOI":"10.1097\/00000441-193211000-00002","volume":"184","author":"S WARREN","year":"1932","unstructured":"WARREN S (1932) The immediate causes of death in cancer. Am J Med Sci 184:610\u2013615","journal-title":"Am J Med Sci"},{"key":"3342_CR20","unstructured":"Song T, Patel A, Punchamannil E, Gilmore L, Iyengar P, Infante R, NSCLC (2025) Cancer cachexia is associated with increased risk of venous and arterial thromboembolic events in CRC and"},{"key":"3342_CR21","doi-asserted-by":"publisher","first-page":"1253587","DOI":"10.3389\/fimmu.2023.1253587","volume":"14","author":"P Cunningham","year":"2023","unstructured":"Cunningham P, Unger CA, Patton EA, Aiken A, Browne A, James E, Aladhami AK, Hope MC 3, VanderVeen BN, Cardaci TD (2023) Platelet status in cancer cachexia progression in ApcMin\/+ mice. Front Immunol 14:1253587","journal-title":"Front Immunol"},{"key":"3342_CR22","doi-asserted-by":"publisher","first-page":"477","DOI":"10.1111\/jth.13612","volume":"15","author":"CJ Reddel","year":"2017","unstructured":"Reddel CJ, Allen JD, Ehteda A, Taylor R, Chen V, Curnow J, Kritharides L, Robertson G (2017) Increased thrombin generation in a mouse model of cancer cachexia is partially interleukin-6 dependent. J Thromb Haemost 15:477\u2013486","journal-title":"J Thromb Haemost"},{"key":"3342_CR23","doi-asserted-by":"publisher","first-page":"630248","DOI":"10.3389\/fcell.2021.630248","volume":"9","author":"B Hu","year":"2021","unstructured":"Hu B, Li H, Zhang X (2021) A balanced act: The effects of GH\u2013GHR\u2013IGF1 Axis on mitochondrial function. Front Cell Dev Biology 9:630248","journal-title":"Front Cell Dev Biology"},{"key":"3342_CR24","doi-asserted-by":"publisher","first-page":"44","DOI":"10.3892\/ijo.2026.5857","volume":"68","author":"T Zhang","year":"2026","unstructured":"Zhang T, Li L, Du C (2026) Beyond the membrane: Internalization and compartmentalization of insulin-like growth factor 1 receptor signaling in cancer pathogenesis and treatment. Int J Oncol 68:44","journal-title":"Int J Oncol"},{"key":"3342_CR25","doi-asserted-by":"publisher","first-page":"591","DOI":"10.1038\/ncponc0934","volume":"4","author":"Y Tao","year":"2007","unstructured":"Tao Y, Pinzi V, Bourhis J, Deutsch E (2007) Mechanisms of disease: signaling of the insulin-like growth factor 1 receptor pathway\u2014therapeutic perspectives in cancer. Nat Clin Pract Oncol 4:591\u2013602","journal-title":"Nat Clin Pract Oncol"},{"key":"3342_CR26","doi-asserted-by":"publisher","first-page":"153601211773664","DOI":"10.1177\/1536012117736648","volume":"16","author":"Y Sun","year":"2017","unstructured":"Sun Y, Sun X, Shen B (2017) Molecular imaging of IGF-1R in cancer. Mol Imaging 16:1536012117736648","journal-title":"Mol Imaging"},{"key":"3342_CR27","doi-asserted-by":"publisher","first-page":"273","DOI":"10.1186\/s13046-023-02850-7","volume":"42","author":"UK Soni","year":"2023","unstructured":"Soni UK, Jenny L, Hegde RS (2023) IGF-1R targeting in cancer\u2013does sub-cellular localization matter? J Experimental Clin Cancer Res 42:273","journal-title":"J Experimental Clin Cancer Res"},{"key":"3342_CR28","doi-asserted-by":"publisher","first-page":"455","DOI":"10.1038\/s41392-023-01705-z","volume":"8","author":"ME Bahar","year":"2023","unstructured":"Bahar ME, Kim HJ, Kim DR (2023) Targeting the RAS\/RAF\/MAPK pathway for cancer therapy: from mechanism to clinical studies. Signal Transduct Target therapy 8:455","journal-title":"Signal Transduct Target therapy"},{"key":"3342_CR29","doi-asserted-by":"crossref","unstructured":"Wang Y, Jamieson SM, Perry JK (2023) Targeting growth hormone in cancer: future perspectives. Endocrine-related Cancer 30","DOI":"10.1530\/ERC-23-0033"},{"key":"3342_CR30","doi-asserted-by":"publisher","first-page":"1397","DOI":"10.1016\/j.jtha.2023.02.029","volume":"21","author":"A Falanga","year":"2023","unstructured":"Falanga A, Marchetti M (2023) Cancer-associated thrombosis: enhanced awareness and pathophysiologic complexity. J Thromb Haemost 21:1397\u20131408","journal-title":"J Thromb Haemost"},{"key":"3342_CR31","doi-asserted-by":"publisher","first-page":"12103","DOI":"10.3390\/ijms241512103","volume":"24","author":"IS Marques","year":"2023","unstructured":"Marques IS, Tavares V, Neto BV, Mota INR, Pereira D, Medeiros R (2023) Long Non-Coding RNAs in Venous Thromboembolism: Where Do We Stand? Int J Mol Sci 24:12103","journal-title":"Int J Mol Sci"},{"key":"3342_CR32","first-page":"1959","volume":"137","author":"FI Mulder","year":"2021","unstructured":"Mulder FI, Horv\u00e0th-Puh\u00f3 E, van Es N, Van Laarhoven H, Pedersen L, Moik F, Ay C, B\u00fcller H, S\u00f8rensen H (2021) Venous thromboembolism in cancer patients: a population-based cohort study. Blood J Am Soc Hematol 137:1959\u20131969","journal-title":"Blood J Am Soc Hematol"},{"key":"3342_CR33","doi-asserted-by":"publisher","first-page":"5293","DOI":"10.3390\/cancers15215293","volume":"15","author":"L Muscat-Baron","year":"2023","unstructured":"Muscat-Baron L, Borg AL, Attard LM, Gatt A, Riva N (2023) Cancer-associated abdominal vein thrombosis. Cancers 15:5293","journal-title":"Cancers"},{"key":"3342_CR34","doi-asserted-by":"publisher","first-page":"495","DOI":"10.1007\/s12185-024-03735-x","volume":"119","author":"K Tatsumi","year":"2024","unstructured":"Tatsumi K (2024) The pathogenesis of cancer-associated thrombosis. Int J Hematol 119:495\u2013504","journal-title":"Int J Hematol"},{"key":"3342_CR35","doi-asserted-by":"publisher","first-page":"824","DOI":"10.1161\/ATVBAHA.123.318779","volume":"43","author":"L Girardi","year":"2023","unstructured":"Girardi L, Wang T-F, Ageno W, Carrier M (2023) Updates in the incidence, pathogenesis, and management of cancer and venous thromboembolism. Arterioscler Thromb Vasc Biol 43:824\u2013831","journal-title":"Arterioscler Thromb Vasc Biol"},{"key":"3342_CR36","doi-asserted-by":"publisher","first-page":"248","DOI":"10.1038\/s41569-022-00787-6","volume":"20","author":"PL Lutsey","year":"2023","unstructured":"Lutsey PL, Zakai NA (2023) Epidemiology and prevention of venous thromboembolism. Nat Reviews Cardiol 20:248\u2013262","journal-title":"Nat Reviews Cardiol"},{"key":"3342_CR37","doi-asserted-by":"crossref","unstructured":"Tsantes AG, Petrou E, Tsante KA, Sokou R, Frantzeskaki F, Domouchtsidou A, Chaldoupis AE, Fortis SP, Piovani D, Nikolopoulos GK (2024) Cancer-associated thrombosis: pathophysiology, laboratory assessment, and current guidelines. Cancers 16, 2082","DOI":"10.3390\/cancers16112082"},{"key":"3342_CR38","doi-asserted-by":"publisher","first-page":"107602962095428","DOI":"10.1177\/1076029620954282","volume":"26","author":"MS Hamza","year":"2020","unstructured":"Hamza MS, Mousa SA (2020) Cancer-associated thrombosis: risk factors, molecular mechanisms, future management. Clin Appl Thromb Hemost 26:1076029620954282","journal-title":"Clin Appl Thromb Hemost"},{"key":"3342_CR39","doi-asserted-by":"publisher","first-page":"380","DOI":"10.3390\/cancers10100380","volume":"10","author":"NB Abdol Razak","year":"2018","unstructured":"Abdol Razak NB, Jones G, Bhandari M, Berndt MC, Metharom P (2018) Cancer-associated thrombosis: an overview of mechanisms, risk factors, and treatment. Cancers 10:380","journal-title":"Cancers"},{"key":"3342_CR40","doi-asserted-by":"publisher","first-page":"202","DOI":"10.1007\/s11239-021-02511-6","volume":"53","author":"SK Chokshi","year":"2022","unstructured":"Chokshi SK, Gaughan JP, Krill L (2022) Incidence and patient characteristics of venous thromboembolism during neoadjuvant chemotherapy for ovarian cancer. J Thromb Thrombolysis 53:202\u2013207","journal-title":"J Thromb Thrombolysis"},{"key":"3342_CR41","doi-asserted-by":"publisher","first-page":"1364","DOI":"10.1002\/ajh.26996","volume":"98","author":"K Giorgio","year":"2023","unstructured":"Giorgio K, Walker RF, MacLehose RF, Adrianzen-Herrera D, Wang W, Alonso A, Zakai NA, Lutsey PL (2023) Venous thromboembolism mortality and trends in older US adults, 2011\u20132019. Am J Hematol 98:1364\u20131373","journal-title":"Am J Hematol"},{"key":"3342_CR42","doi-asserted-by":"publisher","first-page":"030006052312191","DOI":"10.1177\/03000605231219170","volume":"51","author":"EJ Reyes","year":"2023","unstructured":"Reyes EJ, Ruiz-Talero P, Arenas MA, Hern\u00e1ndez-Fl\u00f3rez C, Mu\u00f1oz OM (2023) Factors associated with in-hospital and outpatient survival of patients with different types of stage IV cancer and venous thromboembolism. J Int Med Res 51:03000605231219170","journal-title":"J Int Med Res"},{"key":"3342_CR43","doi-asserted-by":"publisher","first-page":"3870","DOI":"10.1200\/JCO.2011.40.1810","volume":"30","author":"J Ahlbrecht","year":"2012","unstructured":"Ahlbrecht J, Dickmann B, Ay C, Dunkler D, Thaler J, Schmidinger M, Quehenberger P, Haitel A, Zielinski C, Pabinger I (2012) Tumor grade is associated with venous thromboembolism in patients with cancer: results from the Vienna Cancer and Thrombosis Study. J Clin Oncol 30:3870\u20133875","journal-title":"J Clin Oncol"},{"key":"3342_CR44","doi-asserted-by":"crossref","unstructured":"Ording AG, Christensen TD, Skj\u00f8th F, Noble S, H\u00f8jen AA, M\u00f8rkved AL, Larsen TB, Petersen RH, Meldgaard P, Jakobsen E (2024) Risk of venous thromboembolism in patients with stage III and IV non\u2013small-cell lung cancer: nationwide descriptive cohort study. Clinical Lung Cancer 25, 407\u2013416. e401","DOI":"10.1016\/j.cllc.2024.04.004"},{"key":"3342_CR45","doi-asserted-by":"publisher","first-page":"9","DOI":"10.1016\/j.beha.2008.12.001","volume":"22","author":"T Wun","year":"2009","unstructured":"Wun T, White RH (2009) Epidemiology of cancer-related venous thromboembolism. Best Pract Res Clin Haematol 22:9\u201323","journal-title":"Best Pract Res Clin Haematol"},{"key":"3342_CR46","doi-asserted-by":"publisher","first-page":"71","DOI":"10.1111\/bjh.19414","volume":"205","author":"R Alikhan","year":"2024","unstructured":"Alikhan R, Gomez K, Maraveyas A, Noble S, Young A, Thomas M, Haematology BS (2024) .f. Cancer-associated venous thrombosis in adults: A British Society for Haematology Guideline. Br J Haematol 205:71\u201387","journal-title":"Br J Haematol"},{"key":"3342_CR47","doi-asserted-by":"publisher","first-page":"1027","DOI":"10.1186\/s12885-024-12799-1","volume":"24","author":"C Kusunoki","year":"2024","unstructured":"Kusunoki C, Uemura M, Osaki M, Takiguchi N, Kitakaze M, Paku M, Sekido Y, Takeda M, Hata T, Hamabe A (2024) Postoperative venous thromboembolism after surgery for locally recurrent rectal cancer. BMC Cancer 24:1027","journal-title":"BMC Cancer"},{"key":"3342_CR48","doi-asserted-by":"publisher","first-page":"222","DOI":"10.1038\/s41397-020-00201-9","volume":"21","author":"V Tavares","year":"2021","unstructured":"Tavares V, Pinto R, Assis J, Coelho S, Brandao M, Alves S, Pereira D, Medeiros R (2021) Implications of venous thromboembolism GWAS reported genetic makeup in the clinical outcome of ovarian cancer patients. Pharmacogenomics J 21:222\u2013232","journal-title":"Pharmacogenomics J"},{"key":"3342_CR49","doi-asserted-by":"publisher","first-page":"1630","DOI":"10.3390\/life14121630","volume":"14","author":"IG de Melo","year":"2024","unstructured":"de Melo IG, Tavares V, Savva-Bordalo J, Rei M, Liz-Pimenta J, Pereira D, Medeiros R (2024) Endothelial Dysfunction Markers in Ovarian Cancer: VTE Risk and Tumour Prognostic Outcomes. Life 14:1630","journal-title":"Life"},{"key":"3342_CR50","doi-asserted-by":"publisher","first-page":"4845","DOI":"10.3390\/cimb46050292","volume":"46","author":"IG de Melo","year":"2024","unstructured":"de Melo IG, Tavares V, Pereira D, Medeiros R (2024) Contribution of Endothelial Dysfunction to Cancer Susceptibility and Progression: A Comprehensive Narrative Review on the Genetic Risk Component. Curr Issues Mol Biol 46:4845\u20134873","journal-title":"Curr Issues Mol Biol"},{"key":"3342_CR51","doi-asserted-by":"publisher","first-page":"e12728","DOI":"10.1002\/rth2.12728","volume":"6","author":"R Cantrell","year":"2022","unstructured":"Cantrell R, Palumbo JS (2022) Hemostasis and tumor immunity. Res Pract Thromb Haemostasis 6:e12728","journal-title":"Res Pract Thromb Haemostasis"},{"key":"3342_CR52","doi-asserted-by":"publisher","first-page":"S59","DOI":"10.1016\/S0049-3848(13)70024-0","volume":"131","author":"A Falanga","year":"2013","unstructured":"Falanga A, Russo L, Verzeroli C (2013) Mechanisms of thrombosis in cancer. Thromb Res 131:S59\u2013S62","journal-title":"Thromb Res"},{"key":"3342_CR53","doi-asserted-by":"crossref","unstructured":"Mege D, Aubert M, Lacroix R, Dignat-George F, Panicot-Dubois L, Dubois C (2019) Involvement of platelets in cancers. In Proceedings of the Seminars in thrombosis and hemostasis, ; pp. 569\u2013575","DOI":"10.1055\/s-0039-1693475"},{"key":"3342_CR54","doi-asserted-by":"publisher","first-page":"527","DOI":"10.1002\/mc.23398","volume":"61","author":"ET Alexander","year":"2022","unstructured":"Alexander ET, Gilmour SK (2022) Immunomodulatory role of thrombin in cancer progression. Mol Carcinog 61:527\u2013536","journal-title":"Mol Carcinog"},{"key":"3342_CR55","doi-asserted-by":"publisher","first-page":"2733","DOI":"10.1111\/jth.15880","volume":"20","author":"F Moik","year":"2022","unstructured":"Moik F, Ay C (2022) Hemostasis and cancer: Impact of haemostatic biomarkers for the prediction of clinical outcomes in patients with cancer. J Thromb Haemost 20:2733\u20132745","journal-title":"J Thromb Haemost"},{"key":"3342_CR56","doi-asserted-by":"publisher","first-page":"87","DOI":"10.3892\/ijmm.2021.4920","volume":"47","author":"Y Meng","year":"2021","unstructured":"Meng Y, Yin Q, Ma Q, Qin H, Zhang J, Zhang B, Pang H, Tian H (2021) FXII regulates the formation of deep vein thrombosis via the PI3K\/AKT signaling pathway in mice. Int J Mol Med 47:87","journal-title":"Int J Mol Med"},{"key":"3342_CR57","doi-asserted-by":"publisher","first-page":"60","DOI":"10.1186\/s40364-023-00504-6","volume":"11","author":"SE Ahmadi","year":"2023","unstructured":"Ahmadi SE, Shabannezhad A, Kahrizi A, Akbar A, Safdari SM, Hoseinnezhad T, Zahedi M, Sadeghi S, Mojarrad MG, Safa M (2023) Tissue factor (coagulation factor III): a potential double-edge molecule to be targeted and re-targeted toward cancer. Biomark Res 11:60","journal-title":"Biomark Res"},{"key":"3342_CR58","doi-asserted-by":"publisher","first-page":"1310","DOI":"10.1111\/jth.13002","volume":"13","author":"GM Thomas","year":"2015","unstructured":"Thomas GM, Brill A, Mezouar S, Crescence L, Gallant M, Dubois C, Wagner DD (2015) Tissue factor expressed by circulating cancer cell-derived microparticles drastically increases the incidence of deep vein thrombosis in mice. J Thromb Haemost 13:1310\u20131319","journal-title":"J Thromb Haemost"},{"key":"3342_CR59","doi-asserted-by":"publisher","first-page":"146","DOI":"10.1016\/j.bj.2019.07.001","volume":"43","author":"H-Y Lee","year":"2020","unstructured":"Lee H-Y, Yu N-Y, Lee S-H, Tsai H-J, Wu C-C, Cheng J-C, Chen D-P, Wang Y-R, Tseng C-P (2020) Podoplanin promotes cancer-associated thrombosis and contributes to the unfavorable overall survival in an ectopic xenograft mouse model of oral cancer. Biomedical J 43:146\u2013162","journal-title":"Biomedical J"},{"key":"3342_CR60","doi-asserted-by":"publisher","first-page":"104","DOI":"10.1111\/jth.15544","volume":"20","author":"T Sasano","year":"2022","unstructured":"Sasano T, Gonzalez-Delgado R, Mu\u00f1oz NM, Carlos\u2010Alcade W, Cho MS, Sheth RA, Sood AK, Afshar\u2010Kharghan V (2022) Podoplanin promotes tumor growth, platelet aggregation, and venous thrombosis in murine models of ovarian cancer. J Thromb Haemost 20:104\u2013114","journal-title":"J Thromb Haemost"},{"key":"3342_CR61","doi-asserted-by":"publisher","first-page":"1276","DOI":"10.1016\/j.ajpath.2018.01.016","volume":"188","author":"A Kunita","year":"2018","unstructured":"Kunita A, Baeriswyl V, Meda C, Cabuy E, Takeshita K, Giraudo E, Wicki A, Fukayama M, Christofori G (2018) Inflammatory cytokines induce podoplanin expression at the tumor invasive front. Am J Pathol 188:1276\u20131288","journal-title":"Am J Pathol"},{"key":"3342_CR62","doi-asserted-by":"publisher","first-page":"5527","DOI":"10.21037\/jtd.2019.11.26","volume":"11","author":"R Abuduhalike","year":"2019","unstructured":"Abuduhalike R, Sun J, Zhao L, Mahemuti A (2019) Correlation study of venous thromboembolism with SAA, IL-1, and TNF-a levels and gene polymorphisms in Chinese population. J Thorac disease 11:5527","journal-title":"J Thorac disease"},{"key":"3342_CR63","doi-asserted-by":"publisher","first-page":"928","DOI":"10.3390\/biom14080928","volume":"14","author":"V Tavares","year":"2024","unstructured":"Tavares V, Savva-Bordalo J, Rei M, Liz-Pimenta J, Assis J, Pereira D, Medeiros R (2024) Plasma microRNA Environment Linked to Tissue Factor Pathway and Cancer-Associated Thrombosis: Prognostic Significance in Ovarian Cancer. Biomolecules 14:928","journal-title":"Biomolecules"},{"key":"3342_CR64","doi-asserted-by":"publisher","first-page":"30","DOI":"10.1007\/s11239-021-02526-z","volume":"53","author":"KC Zapponi","year":"2022","unstructured":"Zapponi KC, Orsi FA, Cunha JLR, de Brito IR, Romano AVC, Bittar LF, De Paula EV, Penteado CF, Montalv\u00e3o S, Annichino-Bizzacchi JM (2022) Neutrophil activation and circulating neutrophil extracellular traps are increased in venous thromboembolism patients for at least one year after the clinical event. J Thromb Thrombolysis 53:30\u201342","journal-title":"J Thromb Thrombolysis"},{"key":"3342_CR65","doi-asserted-by":"publisher","first-page":"3132","DOI":"10.3748\/wjg.v28.i26.3132","volume":"28","author":"J-C Li","year":"2022","unstructured":"Li J-C, Zou X-M, Yang S-F, Jin J-Q, Zhu L, Li C-J, Yang H, Zhang A-G, Zhao T-Q, Chen C-Y (2022) Neutrophil extracellular traps participate in the development of cancer-associated thrombosis in patients with gastric cancer. World J Gastroenterol 28:3132","journal-title":"World J Gastroenterol"},{"key":"3342_CR66","doi-asserted-by":"publisher","first-page":"S35","DOI":"10.1016\/j.thromres.2021.12.018","volume":"213","author":"A Rosell","year":"2022","unstructured":"Rosell A, Martinod K, Mackman N, Th\u00e5lin C (2022) Neutrophil extracellular traps and cancer-associated thrombosis. Thromb Res 213:S35\u2013S41","journal-title":"Thromb Res"},{"key":"3342_CR67","doi-asserted-by":"publisher","first-page":"67","DOI":"10.1186\/s12959-023-00512-4","volume":"21","author":"W Li","year":"2023","unstructured":"Li W, Wang Z, Su Cg, Liao Z, Pei Y, Wang J, Li Z, Fu S, Liu J (2023) The effect of neutrophil extracellular traps in venous thrombosis. Thromb J 21:67","journal-title":"Thromb J"},{"key":"3342_CR68","doi-asserted-by":"publisher","first-page":"e6935","DOI":"10.1002\/cam4.6935","volume":"13","author":"M Wang","year":"2024","unstructured":"Wang M, Lv X, Wang Y, Li Y, Li H, Shen Z, Zhao L (2024) Biomarkers of peripheral blood neutrophil extracellular traps in the diagnosis and progression of malignant tumors. Cancer Med 13:e6935","journal-title":"Cancer Med"},{"key":"3342_CR69","doi-asserted-by":"publisher","first-page":"81","DOI":"10.35366\/112486","volume":"10","author":"S Guzm\u00e1n-Silahua","year":"2023","unstructured":"Guzm\u00e1n-Silahua S, Barreno-Rocha SG, del Carmen Rodr\u00edguez-D\u00e1vila S, S\u00e1nchez-Cazares K, Barreno-Rocha MA, Rubio-Jurado B, Nava-Zavala AH (2023) D\u00edmero D y mol\u00e9culas de adhesi\u00f3n relacionadas a enfermedad tromboemb\u00f3lica. Salud Jalisco 10:81\u201390","journal-title":"Salud Jalisco"},{"key":"3342_CR70","doi-asserted-by":"publisher","first-page":"S22","DOI":"10.1016\/j.thromres.2021.12.027","volume":"213","author":"E Yeini","year":"2022","unstructured":"Yeini E, Satchi-Fainaro R (2022) The role of P-selectin in cancer-associated thrombosis and beyond. Thromb Res 213:S22\u2013S28","journal-title":"Thromb Res"},{"key":"3342_CR71","doi-asserted-by":"crossref","unstructured":"Rena NMRA, Bakta IM, Suega K (2025) High levels of soluble P-selectin, neutrophil extracellular traps, and myeloperoxidase as risk factor of deep vein thrombosis in malignancy patients receiving platinum-based chemotherapy. F1000Research 13, 427","DOI":"10.12688\/f1000research.146982.2"},{"key":"3342_CR72","doi-asserted-by":"publisher","first-page":"1713","DOI":"10.1136\/gutjnl-2020-320608","volume":"70","author":"M Sano","year":"2021","unstructured":"Sano M, Takahashi R, Ijichi H, Ishigaki K, Yamada T, Miyabayashi K, Kimura G, Mizuno S, Kato H, Fujiwara H (2021) Blocking VCAM-1 inhibits pancreatic tumour progression and cancer-associated thrombosis\/thromboembolism. Gut 70:1713\u20131723","journal-title":"Gut"},{"key":"3342_CR73","doi-asserted-by":"publisher","first-page":"305","DOI":"10.1007\/s10549-020-06054-x","volume":"186","author":"EE Tzekaki","year":"2021","unstructured":"Tzekaki EE, Geromichalos G, Lavrentiadou SN, Tsantarliotou MP, Pantazaki AA, Papaspyropoulos A (2021) Oleuropein is a natural inhibitor of PAI-1-mediated proliferation in human ER-\/PR-breast cancer cells. Breast Cancer Res Treat 186:305\u2013316","journal-title":"Breast Cancer Res Treat"},{"key":"3342_CR74","doi-asserted-by":"publisher","first-page":"1618","DOI":"10.1111\/jth.15701","volume":"20","author":"T Frischmuth","year":"2022","unstructured":"Frischmuth T, Hindberg K, Aukrust P, Ueland T, Br\u00e6kkan SK, Hansen JB, Morelli VM (2022) Elevated plasma levels of plasminogen activator inhibitor-1 are associated with risk of future incident venous thromboembolism. J Thromb Haemost 20:1618\u20131626","journal-title":"J Thromb Haemost"},{"key":"3342_CR75","doi-asserted-by":"publisher","first-page":"111","DOI":"10.1007\/s11239-006-9054-z","volume":"22","author":"A Eroglu","year":"2006","unstructured":"Eroglu A, Ulu A, Akar N (2006) Plasminogen activator inhibitor-1 gene 4G\/5G polymorphism in cancer patients with and without thrombosis. J Thromb Thrombolysis 22:111","journal-title":"J Thromb Thrombolysis"},{"key":"3342_CR76","doi-asserted-by":"publisher","first-page":"2191","DOI":"10.1161\/ATVBAHA.124.320938","volume":"44","author":"HB Khoukaz","year":"2024","unstructured":"Khoukaz HB, Vadali M, Schoenherr A, Ramirez-Perez FI, Morales-Quinones M, Sun Z, Fujie S, Foote CA, Lyu Z, Zeng S (2024) PAI-1 regulates the cytoskeleton and intrinsic stiffness of vascular smooth muscle cells. Arterioscler Thromb Vasc Biol 44:2191\u20132203","journal-title":"Arterioscler Thromb Vasc Biol"},{"key":"3342_CR77","doi-asserted-by":"publisher","first-page":"2356","DOI":"10.3390\/cancers16132356","volume":"16","author":"V Tavares","year":"2024","unstructured":"Tavares V, Savva-Bordalo J, Rei M, Liz-Pimenta J, Assis J, Pereira D, Medeiros R (2024) Haemostatic Gene Expression in Cancer-Related Immunothrombosis: Contribution for Venous Thromboembolism and Ovarian Tumour Behaviour. Cancers 16:2356","journal-title":"Cancers"},{"key":"3342_CR78","doi-asserted-by":"publisher","first-page":"36","DOI":"10.1016\/j.jbior.2015.06.001","volume":"59","author":"GF Guidetti","year":"2015","unstructured":"Guidetti GF, Canobbio I, Torti M (2015) PI3K\/Akt in platelet integrin signaling and implications in thrombosis. Adv Biol Regul 59:36\u201352","journal-title":"Adv Biol Regul"},{"key":"3342_CR79","doi-asserted-by":"publisher","first-page":"2260","DOI":"10.1161\/01.CIR.0000144309.87183.FB","volume":"110","author":"E Conti","year":"2004","unstructured":"Conti E, Carrozza C, Capoluongo E, Volpe M, Crea F, Zuppi C, Andreotti F (2004) Insulin-like growth factor-1 as a vascular protective factor. Circulation 110:2260\u20132265","journal-title":"Circulation"},{"key":"3342_CR80","doi-asserted-by":"publisher","first-page":"R1","DOI":"10.1530\/JME-14-0215","volume":"54","author":"LA Bach","year":"2015","unstructured":"Bach LA (2015) Endothelial cells and the IGF system. J Mol Endocrinol 54:R1\u201313","journal-title":"J Mol Endocrinol"},{"key":"3342_CR81","doi-asserted-by":"publisher","first-page":"1760","DOI":"10.1161\/STROKEAHA.116.016563","volume":"48","author":"H Saber","year":"2017","unstructured":"Saber H, Himali JJ, Beiser AS, Shoamanesh A, Pikula A, Roubenoff R, Romero JR, Kase CS, Vasan RS, Seshadri S (2017) Serum insulin-like growth factor 1 and the risk of ischemic stroke: the Framingham study. Stroke 48:1760\u20131765","journal-title":"Stroke"},{"key":"3342_CR82","doi-asserted-by":"publisher","first-page":"435","DOI":"10.1161\/01.ATV.0000105902.89459.09","volume":"24","author":"P Delafontaine","year":"2004","unstructured":"Delafontaine P, Song Y-H, Li Y (2004) Expression, regulation, and function of IGF-1, IGF-1R, and IGF-1 binding proteins in blood vessels. Arterioscler Thromb Vasc Biol 24:435\u2013444","journal-title":"Arterioscler Thromb Vasc Biol"},{"key":"3342_CR83","doi-asserted-by":"publisher","first-page":"1222","DOI":"10.1161\/01.RES.0000021127.83364.7D","volume":"90","author":"W Che","year":"2002","unstructured":"Che W, Lerner-Marmarosh N, Huang Q, Osawa M, Ohta S, Yoshizumi M, Glassman M, Lee J-D, Yan C, Berk BC (2002) Insulin-like growth factor-1 enhances inflammatory responses in endothelial cells: role of Gab1 and MEKK3 in TNF-\u03b1\u2013induced c-Jun and NF-\u03baB activation and adhesion molecule expression. Circul Res 90:1222\u20131230","journal-title":"Circul Res"},{"key":"3342_CR84","doi-asserted-by":"publisher","first-page":"270","DOI":"10.1007\/s12020-008-9088-4","volume":"33","author":"C Erem","year":"2008","unstructured":"Erem C, Nuhoglu \u0130, Kocak M, Yilmaz M, Sipahi ST, Ucuncu O, Ersoz HO (2008) Blood coagulation and fibrinolysis in patients with acromegaly: increased plasminogen activator inhibitor-1 (PAI-1), decreased tissue factor pathway inhibitor (TFPI), and an inverse correlation between growth hormone and TFPI. Endocrine 33:270\u2013276","journal-title":"Endocrine"},{"key":"3342_CR85","first-page":"T","volume":"43","author":"C Englisch","year":"2023","unstructured":"Englisch C, Moik F, Thaler J, Koder S, Preusser M, Pabinger I, Ay C (2023) Tissue factor pathway inhibitor is associated with risk of venous thromboembolism and all-cause mortality in patients with cancer. H\u00e4mostaseologie 43:T\u201306","journal-title":"H\u00e4mostaseologie"},{"key":"3342_CR86","doi-asserted-by":"publisher","first-page":"109099","DOI":"10.1016\/j.biopha.2019.109099","volume":"117","author":"Y Chen","year":"2019","unstructured":"Chen Y, Zheng Y, Xin L, Zhong S, Liu A, Lai W, Liu L, Lin C, Liao C, Zeng (2019) J. 15-epi-lipoxin A4 inhibits TNF-\u03b1-induced tissue factor expression via the PI3K\/AKT\/NF-\u03baB axis in human umbilical vein endothelial cells. Biomed Pharmacother 117:109099","journal-title":"Biomed Pharmacother"},{"key":"3342_CR87","doi-asserted-by":"publisher","first-page":"44","DOI":"10.1097\/CM9.0000000000002846","volume":"137","author":"Y Wang","year":"2024","unstructured":"Wang Y, Dong Z, An Z, Jin W (2024) Cancer cachexia: focus on cachexia factors and inter-organ communication. Chin Med J 137:44\u201362","journal-title":"Chin Med J"},{"key":"3342_CR88","doi-asserted-by":"publisher","first-page":"715","DOI":"10.1111\/cas.16078","volume":"115","author":"Y Nakamura","year":"2024","unstructured":"Nakamura Y, Saldajeno DP, Kawaguchi K, Kawaoka S (2024) Progressive, multi-organ, and multi\u2010layered nature of cancer cachexia. Cancer Sci 115:715\u2013722","journal-title":"Cancer Sci"},{"key":"3342_CR89","doi-asserted-by":"publisher","first-page":"114802","DOI":"10.1016\/j.biopha.2023.114802","volume":"163","author":"S Muthamil","year":"2023","unstructured":"Muthamil S, Kim HY, Jang H-J, Lyu J-H, Shin UC, Go Y, Park S-H, Lee HG, Park JH (2023) Understanding the relationship between cancer associated cachexia and hypoxia-inducible factor-1. Biomed Pharmacother 163:114802","journal-title":"Biomed Pharmacother"},{"key":"3342_CR90","doi-asserted-by":"publisher","first-page":"4967","DOI":"10.3892\/mmr.2020.11608","volume":"22","author":"W Yang","year":"2020","unstructured":"Yang W, Huang J, Wu H, Wang Y, Du Z, Ling Y, Wang W, Wu Q, Gao W (2020) Molecular mechanisms of cancer cachexia\u2013induced muscle atrophy. Mol Med Rep 22:4967\u20134980","journal-title":"Mol Med Rep"},{"key":"3342_CR91","doi-asserted-by":"publisher","first-page":"54","DOI":"10.1186\/s13045-023-01454-0","volume":"16","author":"T Setiawan","year":"2023","unstructured":"Setiawan T, Sari IN, Wijaya YT, Julianto NM, Muhammad JA, Lee H, Chae JH, Kwon HY (2023) Cancer cachexia: molecular mechanisms and treatment strategies. J Hematol Oncol 16:54","journal-title":"J Hematol Oncol"},{"key":"3342_CR92","first-page":"2070","volume":"18","author":"J Geppert","year":"2024","unstructured":"Geppert J, Rohm M (2024) Cancer cachexia: biomarkers and the influence of age. Mol Oncol 18:2070\u20132086","journal-title":"Mol Oncol"},{"key":"3342_CR93","doi-asserted-by":"publisher","first-page":"389","DOI":"10.1016\/j.clnu.2007.03.008","volume":"26","author":"DR Thomas","year":"2007","unstructured":"Thomas DR (2007) Loss of skeletal muscle mass in aging: examining the relationship of starvation, sarcopenia and cachexia. Clin Nutr 26:389\u2013399","journal-title":"Clin Nutr"},{"key":"3342_CR94","doi-asserted-by":"publisher","first-page":"1163","DOI":"10.1200\/JOP.2016.016832","volume":"12","author":"AR Bruggeman","year":"2016","unstructured":"Bruggeman AR, Kamal AH, LeBlanc TW, Ma JD, Baracos VE, Roeland EJ (2016) Cancer cachexia: beyond weight loss. J Oncol Pract 12:1163\u20131171","journal-title":"J Oncol Pract"},{"key":"3342_CR95","doi-asserted-by":"publisher","first-page":"1395","DOI":"10.3390\/cancers16071395","volume":"16","author":"L Caeiro","year":"2024","unstructured":"Caeiro L, Jaramillo Quiroz S, Hegarty JS, Grewe E, Garcia JM, Anderson LJ (2024) Clinical relevance of physical function outcomes in cancer cachexia. Cancers 16:1395","journal-title":"Cancers"},{"key":"3342_CR96","doi-asserted-by":"crossref","unstructured":"Ni J, Zhang L (2020) Cancer cachexia: definition, staging, and emerging treatments. Cancer Manage Res 5597\u20135605","DOI":"10.2147\/CMAR.S261585"},{"key":"3342_CR97","doi-asserted-by":"publisher","first-page":"100282","DOI":"10.1016\/j.advnut.2024.100282","volume":"15","author":"T Takaoka","year":"2024","unstructured":"Takaoka T, Yaegashi A, Watanabe D (2024) Prevalence of and survival with cachexia among patients with cancer: a systematic review and meta-analysis. Adv Nutr 15:100282","journal-title":"Adv Nutr"},{"key":"3342_CR98","doi-asserted-by":"publisher","first-page":"1293","DOI":"10.1007\/s10147-021-01912-0","volume":"26","author":"T Takeda","year":"2021","unstructured":"Takeda T, Sasaki T, Suzumori C, Mie T, Furukawa T, Yamada Y, Kasuga A, Matsuyama M, Ozaka M, Sasahira N (2021) The impact of cachexia and sarcopenia in elderly pancreatic cancer patients receiving palliative chemotherapy. Int J Clin Oncol 26:1293\u20131303","journal-title":"Int J Clin Oncol"},{"key":"3342_CR99","doi-asserted-by":"publisher","first-page":"1362244","DOI":"10.3389\/fonc.2024.1362244","volume":"14","author":"JB Permuth","year":"2024","unstructured":"Permuth JB, Park MA, Chen D-T, Basinski T, Powers BD, Gwede CK, Dezsi KB, Gomez M, Vyas SL, Biachi T (2024) Leveraging real-world data to predict cancer cachexia stage, quality of life, and survival in a racially and ethnically diverse multi-institutional cohort of treatment-na\u00efve patients with pancreatic ductal adenocarcinoma. Front Oncol 14:1362244","journal-title":"Front Oncol"},{"key":"3342_CR100","doi-asserted-by":"publisher","first-page":"489","DOI":"10.1016\/S1470-2045(10)70218-7","volume":"12","author":"K Fearon","year":"2011","unstructured":"Fearon K, Strasser F, Anker SD, Bosaeus I, Bruera E, Fainsinger RL, Jatoi A, Loprinzi C, MacDonald N, Mantovani G (2011) Definition and classification of cancer cachexia: an international consensus. Lancet Oncol 12:489\u2013495","journal-title":"Lancet Oncol"},{"key":"3342_CR101","doi-asserted-by":"publisher","first-page":"3952","DOI":"10.3390\/ijms26093952","volume":"26","author":"S Satari","year":"2025","unstructured":"Satari S, Mota IN, Silva ACL, Brito HO, Oliveira PA, da Gil RM, Medeiros R (2025) Hallmarks of cancer cachexia: sexual dimorphism in related pathways. Int J Mol Sci 26:3952","journal-title":"Int J Mol Sci"},{"key":"3342_CR102","doi-asserted-by":"publisher","first-page":"5590","DOI":"10.3390\/cancers15235590","volume":"15","author":"CR Mariean","year":"2023","unstructured":"Mariean CR, Tiuc\u0103 OM, Mariean A, Cotoi OS (2023) Cancer cachexia: new insights and future directions. Cancers 15:5590","journal-title":"Cancers"},{"key":"3342_CR103","doi-asserted-by":"publisher","first-page":"1980","DOI":"10.3390\/nu13061980","volume":"13","author":"P Bossi","year":"2021","unstructured":"Bossi P, Delrio P, Mascheroni A, Zanetti M (2021) The spectrum of malnutrition\/cachexia\/sarcopenia in oncology according to different cancer types and settings: a narrative review. Nutrients 13:1980","journal-title":"Nutrients"},{"key":"3342_CR104","doi-asserted-by":"publisher","first-page":"94","DOI":"10.1186\/s13550-021-00834-2","volume":"11","author":"J Han","year":"2021","unstructured":"Han J, Harrison L, Patzelt L, Wu M, Junker D, Herzig S, Berriel Diaz M, Karampinos DC (2021) Imaging modalities for diagnosis and monitoring of cancer cachexia. EJNMMI Res 11:94","journal-title":"EJNMMI Res"},{"key":"3342_CR105","doi-asserted-by":"publisher","first-page":"619","DOI":"10.1002\/jcsm.12528","volume":"11","author":"S Peixoto da Silva","year":"2020","unstructured":"Peixoto da Silva S, Santos JM, Costa e Silva MP, da Gil RM, Medeiros R (2020) Cancer cachexia and its pathophysiology: links with sarcopenia, anorexia and asthenia. J cachexia sarcopenia muscle 11:619\u2013635","journal-title":"J cachexia sarcopenia muscle"},{"key":"3342_CR106","doi-asserted-by":"publisher","first-page":"1686","DOI":"10.3390\/antiox11091686","volume":"11","author":"Y Ji","year":"2022","unstructured":"Ji Y, Li M, Chang M, Liu R, Qiu J, Wang K, Deng C, Shen Y, Zhu J, Wang W (2022) Inflammation: roles in skeletal muscle atrophy. Antioxidants 11:1686","journal-title":"Antioxidants"},{"key":"3342_CR107","doi-asserted-by":"publisher","first-page":"2321","DOI":"10.3390\/ijms21072321","volume":"21","author":"GWPd Fonseca","year":"2020","unstructured":"Fonseca GWPd, Farkas J, Dora E, von Haehling S, Lainscak M (2020) Cancer cachexia and related metabolic dysfunction. Int J Mol Sci 21:2321","journal-title":"Int J Mol Sci"},{"key":"3342_CR108","doi-asserted-by":"publisher","first-page":"2118","DOI":"10.1016\/j.cellsig.2012.07.016","volume":"24","author":"K Mirza","year":"2012","unstructured":"Mirza K, Tisdale M (2012) Role of Ca2\u2009+\u2009in proteolysis-inducing factor (PIF)-induced atrophy of skeletal muscle. Cell Signal 24:2118\u20132122","journal-title":"Cell Signal"},{"key":"3342_CR109","doi-asserted-by":"publisher","first-page":"213","DOI":"10.3389\/fphys.2017.00213","volume":"8","author":"F Pin","year":"2017","unstructured":"Pin F, Minero VG, Penna F, Muscaritoli M, De Tullio R, Baccino FM, Costelli P (2017) Interference with Ca2+-dependent proteolysis does not alter the course of muscle wasting in experimental cancer cachexia. Front Physiol 8:213","journal-title":"Front Physiol"},{"key":"3342_CR110","doi-asserted-by":"publisher","first-page":"5","DOI":"10.1016\/S0304-4165(00)00050-7","volume":"1475","author":"Sl Busquets","year":"2000","unstructured":"Busquets Sl, Garc\u0131\u0301a-Mart\u0131\u0301nez C, Alvarez B, Carb\u00f3 N, L\u00f3pez-Soriano FJ, Argil\u00e9s JM (2000) Calpain-3 gene expression is decreased during experimental cancer cachexia. Biochim et Biophys Acta (BBA)-General Subj 1475:5\u20139","journal-title":"Biochim et Biophys Acta (BBA)-General Subj"},{"key":"3342_CR111","doi-asserted-by":"publisher","first-page":"75","DOI":"10.1186\/s12885-016-2121-8","volume":"16","author":"TC Mueller","year":"2016","unstructured":"Mueller TC, Bachmann J, Prokopchuk O, Friess H, Martignoni ME (2016) Molecular pathways leading to loss of skeletal muscle mass in cancer cachexia\u2013can findings from animal models be translated to humans? BMC Cancer 16:75","journal-title":"BMC Cancer"},{"key":"3342_CR112","doi-asserted-by":"publisher","first-page":"15150","DOI":"10.1080\/07391102.2023.2187232","volume":"41","author":"A Bhattacharjee","year":"2023","unstructured":"Bhattacharjee A, Pranto SAM, Ahammad I, Chowdhury ZM, Juliana FM, Das KC, Keya CA, Salimullah M (2023) High risk genetic variants of human insulin receptor substrate 1 (IRS1) infer structural instability and functional interference. J Biomol Struct Dynamics 41:15150\u201315164","journal-title":"J Biomol Struct Dynamics"},{"key":"3342_CR113","doi-asserted-by":"publisher","first-page":"e13829","DOI":"10.1097\/MD.0000000000013829","volume":"97","author":"G-P Xu","year":"2018","unstructured":"Xu G-P, Chen W-X, Xie W-Y, Wu L-F (2018) The association between IGF1 Gene 3\u2019-UTR polymorphisms and cancer risk: a meta-analysis. Medicine 97:e13829","journal-title":"Medicine"},{"key":"3342_CR114","doi-asserted-by":"publisher","first-page":"659","DOI":"10.1093\/annonc\/mdr293","volume":"23","author":"K Shitara","year":"2012","unstructured":"Shitara K, Ito S, Misawa K, Ito Y, Ito H, Hosono S, Watanabe M, Tajima K, Tanaka H, Muro K (2012) Genetic polymorphism of IGF-I predicts recurrence in patients with gastric cancer who have undergone curative gastrectomy. Ann Oncol 23:659\u2013664","journal-title":"Ann Oncol"},{"key":"3342_CR115","doi-asserted-by":"publisher","first-page":"4820","DOI":"10.1210\/jc.2007-0887","volume":"92","author":"M Johansson","year":"2007","unstructured":"Johansson M, McKay JD, Wiklund F, Rinaldi S, Verheus M, Van Gils CH, Hallmans Gr, B\u00e4lter K, Adami H-O, Gr\u00f6nberg H (2007) Implications for prostate cancer of insulin-like growth factor-I (IGF-I) genetic variation and circulating IGF-I levels. J Clin Endocrinol Metabolism 92:4820\u20134826","journal-title":"J Clin Endocrinol Metabolism"},{"key":"3342_CR116","doi-asserted-by":"publisher","unstructured":"Niel TA (2023) Mechanistic Evaluation of Naturally Occurring IGF1R 3\u2019UTR Gene Variants Altering Disease Outcomes in Women. https:\/\/doi.org\/10.33015\/dominican.edu\/2023.BIO.06","DOI":"10.33015\/dominican.edu\/2023.BIO.06"},{"key":"3342_CR117","doi-asserted-by":"publisher","first-page":"3","DOI":"10.1186\/s13058-015-0663-3","volume":"18","author":"S de Groot","year":"2016","unstructured":"de Groot S, Charehbili A, van Laarhoven HW, Mooyaart AL, Dekker-Ensink NG, van de Ven S, Janssen LG, Swen JJ, Smit VT, Heijns JB (2016) Insulin-like growth factor 1 receptor expression and IGF1R 3129G\u2009>\u2009T polymorphism are associated with response to neoadjuvant chemotherapy in breast cancer patients: results from the NEOZOTAC trial (BOOG 2010-01). Breast Cancer Res 18:3","journal-title":"Breast Cancer Res"},{"key":"3342_CR118","first-page":"512","volume":"41","author":"H Wang","year":"2019","unstructured":"Wang H, Huang W, Yu X, Li W, Huang Y, Mo Z, Gao Y, Zhou Q, Hu Y (2019) Two prostate cancer-associated polymorphisms in the 3\u2032 UTR of IGF1R influences prostate cancer susceptibility by affecting miRNA binding. Oncol Rep 41:512\u2013524","journal-title":"Oncol Rep"},{"key":"3342_CR119","doi-asserted-by":"publisher","first-page":"48","DOI":"10.1016\/j.ghir.2018.02.004","volume":"41","author":"SN Hartin","year":"2018","unstructured":"Hartin SN, Hossain WA, Manzardo AM, Brown S, Fite PJ, Bortolato M, Butler MG (2018) A descriptive study on selected growth parameters and growth hormone receptor gene in healthy young adults from the American Midwest. Growth Hormon IGF Res 41:48\u201353","journal-title":"Growth Hormon IGF Res"},{"key":"3342_CR120","doi-asserted-by":"crossref","unstructured":"Van Dyke AL, Cote ML, Wenzlaff AS, Abrams J, Land S, Iyer P, Schwartz AG (2009) Chromosome 5p region SNPs are associated with risk of NSCLC among women. Journal of Cancer Epidemiology 2009, 242151","DOI":"10.1155\/2009\/242151"},{"key":"3342_CR121","doi-asserted-by":"publisher","first-page":"e29883","DOI":"10.1371\/journal.pone.0029883","volume":"7","author":"T Alfred","year":"2012","unstructured":"Alfred T, Ben-Shlomo Y, Cooper R, Hardy R, Cooper C, Deary IJ, Gaunt TR, Gunnell D, Harris SE, Kumari M (2012) A multi-cohort study of polymorphisms in the GH\/IGF axis and physical capability: the HALCyon programme. PLoS ONE 7:e29883","journal-title":"PLoS ONE"},{"key":"3342_CR122","doi-asserted-by":"publisher","first-page":"487","DOI":"10.1007\/s12020-013-0004-1","volume":"45","author":"FA Marques","year":"2014","unstructured":"Marques FA, Lins TC, Lima RM, Fonseca RMC, de Fran\u00e7a NM, de Oliveira RJ, de Oliveira Cardoso MT, Pereira RW, Pogue R (2014) The exon 3 polymorphism of the growth hormone receptor is a severity-related factor for osteoporosis. Endocrine 45:487\u2013496","journal-title":"Endocrine"},{"key":"3342_CR123","doi-asserted-by":"publisher","first-page":"e0186296","DOI":"10.1371\/journal.pone.0186296","volume":"12","author":"SY Jung","year":"2017","unstructured":"Jung SY, Rohan T, Strickler H, Bea J, Zhang Z-F, Ho G, Crandall C (2017) Genetic variants and traits related to insulin-like growth factor-I and insulin resistance and their interaction with lifestyles on postmenopausal colorectal cancer risk. PLoS ONE 12:e0186296","journal-title":"PLoS ONE"},{"key":"3342_CR124","doi-asserted-by":"publisher","first-page":"567","DOI":"10.1007\/s10549-017-4621-x","volume":"168","author":"C Duggan","year":"2018","unstructured":"Duggan C, Baumgartner RN, Baumgartner KB, Bernstein L, George S, Ballard R, Neuhouser ML, McTiernan A (2018) Genetic variation in TNF\u03b1, PPAR\u03b3, and IRS-1 genes, and their association with breast-cancer survival in the HEAL cohort. Breast Cancer Res Treat 168:567\u2013576","journal-title":"Breast Cancer Res Treat"},{"key":"3342_CR125","doi-asserted-by":"publisher","first-page":"1168942","DOI":"10.3389\/fonc.2023.1168942","volume":"13","author":"M Cheraghpour","year":"2023","unstructured":"Cheraghpour M, Askari M, Tierling S, Shojaee S, Sadeghi A, Ketabi Moghadam P, Khazdouz M, Asadzadeh Aghdaei H, Piroozkhah M, Nazemalhosseini-Mojarad E (2023) A systematic review and meta-analysis for the association of the insulin-like growth factor1 pathway genetic polymorphisms with colorectal cancer susceptibility. Front Oncol 13:1168942","journal-title":"Front Oncol"},{"key":"3342_CR126","doi-asserted-by":"publisher","first-page":"6581","DOI":"10.1007\/s13277-014-1900-6","volume":"35","author":"P Li","year":"2014","unstructured":"Li P, Wang L, Liu L, Jiang H, Ma C, Hao T (2014) Association between IRS-1 Gly972Arg polymorphism and colorectal cancer risk. Tumor Biology 35:6581\u20136585","journal-title":"Tumor Biology"},{"key":"3342_CR127","doi-asserted-by":"publisher","first-page":"2929","DOI":"10.1007\/s13277-013-0855-3","volume":"34","author":"H Zhang","year":"2013","unstructured":"Zhang H, Wang A, Ma H, Xu Y (2013) Association between insulin receptor substrate 1 Gly972Arg polymorphism and cancer risk. Tumor Biology 34:2929\u20132936","journal-title":"Tumor Biology"},{"key":"3342_CR128","doi-asserted-by":"publisher","first-page":"328","DOI":"10.1002\/mnfr.201000235","volume":"55","author":"C Marin","year":"2011","unstructured":"Marin C, P\u00e9rez-Mart\u00ednez P, Delgado\u2010Lista J, Gomez P, Rodr\u00edguez F, Yubero\u2010Serrano EM, Garc\u00eda\u2010R\u00edos A, Camargo A, P\u00e9rez\u2010Jim\u00e9nez F, L\u00f3pez\u2010Miranda J (2011) The insulin sensitivity response is determined by the interaction between the G972R polymorphism of the insulin receptor substrate 1 gene and dietary fat. Mol Nutr Food Res 55:328\u2013335","journal-title":"Mol Nutr Food Res"},{"key":"3342_CR129","doi-asserted-by":"publisher","first-page":"191","DOI":"10.5114\/wo.2021.109727","volume":"25","author":"B Smolarz","year":"2021","unstructured":"Smolarz B, Po\u0142a\u0107 I, Romanowicz H (2021) Mammographic breast density and IGF-1 gene polymorphisms rs1520220, rs2946834 and rs6219 in Polish women. Contemp Oncology\/Wsp\u00f3\u0142czesna Onkologia 25:191\u2013197","journal-title":"Contemp Oncology\/Wsp\u00f3\u0142czesna Onkologia"},{"key":"3342_CR130","doi-asserted-by":"crossref","unstructured":"Powell MJ, Dufault SM, Henry JE, Allison AC, Cora R, Benz CC (2019) Pregnancy hypertension and a commonly inherited IGF1R variant (rs2016347) reduce breast cancer risk by enhancing mammary gland involution. Journal of Oncology 2019, 6018432","DOI":"10.1155\/2019\/6018432"},{"key":"3342_CR131","doi-asserted-by":"publisher","first-page":"e923853","DOI":"10.12659\/MSM.923853","volume":"26","author":"H Xie","year":"2020","unstructured":"Xie H, Mao J-s, Hu W (2020) -f. Insulin-Like growth factor 1 (IGF1) pathway member polymorphisms are associated with risk and prognosis of chondrosarcoma. Med Sci Monitor: Int Med J Experimental Clin Res 26:e923853\u2013e923851","journal-title":"Med Sci Monitor: Int Med J Experimental Clin Res"},{"key":"3342_CR132","doi-asserted-by":"publisher","first-page":"085201","DOI":"10.1088\/1751-8113\/44\/8\/085201","volume":"44","author":"L Vinet","year":"2011","unstructured":"Vinet L, Zhedanov A (2011) A \u2018missing\u2019family of classical orthogonal polynomials. J Phys A: Math Theor 44:085201","journal-title":"J Phys A: Math Theor"},{"key":"3342_CR133","doi-asserted-by":"publisher","first-page":"13908","DOI":"10.3390\/ijms241813908","volume":"24","author":"G Falah","year":"2023","unstructured":"Falah G, Sharvit L, Atzmon G (2023) The exon 3-deleted growth hormone receptor (d3GHR) polymorphism\u2014A favorable backdoor mechanism for the GHR function. Int J Mol Sci 24:13908","journal-title":"Int J Mol Sci"},{"key":"3342_CR134","doi-asserted-by":"publisher","first-page":"101","DOI":"10.1530\/EJE-13-0685","volume":"170","author":"CA Glad","year":"2014","unstructured":"Glad CA, Barbosa EJ, Filipsson Nystr\u00f6m H, Carlsson LM, Nilsson S, Nilsson AG, Svensson P-A, Johannsson G (2014) SNPs within the GH-signaling pathway are associated with the early IGF1 response to GH replacement therapy in GHD adults. Eur J Endocrinol 170:101\u2013107","journal-title":"Eur J Endocrinol"},{"key":"3342_CR135","doi-asserted-by":"publisher","first-page":"377","DOI":"10.1042\/CS20100400","volume":"120","author":"E Conti","year":"2011","unstructured":"Conti E, Musumeci MB, De Giusti M, Dito E, Mastromarino V, Autore C, Volpe M (2011) IGF-1 and atherothrombosis: relevance to pathophysiology and therapy. Clin Sci 120:377\u2013402","journal-title":"Clin Sci"},{"key":"3342_CR136","doi-asserted-by":"publisher","first-page":"162","DOI":"10.1016\/j.thromres.2012.09.020","volume":"131","author":"J Thaler","year":"2013","unstructured":"Thaler J, Preusser M, Ay C, Kaider A, Marosi C, Zielinski C, Pabinger I, Hainfellner JA (2013) Intratumoral tissue factor expression and risk of venous thromboembolism in brain tumor patients. Thromb Res 131:162\u2013165","journal-title":"Thromb Res"},{"key":"3342_CR137","doi-asserted-by":"publisher","first-page":"290","DOI":"10.1038\/sj.bjc.6603552","volume":"96","author":"K Uno","year":"2007","unstructured":"Uno K, Homma S, Satoh T, Nakanishi K, Abe D, Matsumoto K, Oki A, Tsunoda H, Yamaguchi I, Nagasawa T (2007) Tissue factor expression as a possible determinant of thromboembolism in ovarian cancer. Br J Cancer 96:290\u2013295","journal-title":"Br J Cancer"},{"key":"3342_CR138","doi-asserted-by":"publisher","first-page":"1675","DOI":"10.1038\/s41598-018-19889-8","volume":"8","author":"C-j Cui","year":"2018","unstructured":"Cui C-j, Wang G-j, Yang S, Huang S-k, Qiao R, Cui W (2018) Tissue Factor-bearing MPs and the risk of venous thrombosis in cancer patients: A meta-analysis. Sci Rep 8:1675","journal-title":"Sci Rep"},{"key":"3342_CR139","doi-asserted-by":"publisher","first-page":"1009","DOI":"10.1111\/jth.14759","volume":"18","author":"MY Najem","year":"2020","unstructured":"Najem MY, Couturaud F, Lemari\u00e9 CA (2020) Cytokine and chemokine regulation of venous thromboembolism. J Thromb Haemost 18:1009\u20131019","journal-title":"J Thromb Haemost"},{"key":"3342_CR140","doi-asserted-by":"publisher","first-page":"742","DOI":"10.1080\/16078454.2019.1687144","volume":"24","author":"D Borgel","year":"2019","unstructured":"Borgel D, Bianchini E, Lasne D, Pascreau T, Saller F (2019) Inflammation in deep vein thrombosis: a therapeutic target? Hematology 24:742\u2013750","journal-title":"Hematology"},{"key":"3342_CR141","doi-asserted-by":"publisher","first-page":"97","DOI":"10.1186\/s12964-023-01110-7","volume":"21","author":"S Ben","year":"2023","unstructured":"Ben S, Huang X, Shi Y, Xu Z, Xiao H (2023) Change in cytokine profiles released by mast cells mediated by lung cancer-derived exosome activation may contribute to cancer-associated coagulation disorders. Cell Communication Signal 21:97","journal-title":"Cell Communication Signal"},{"key":"3342_CR142","doi-asserted-by":"publisher","first-page":"253","DOI":"10.1111\/cei.12308","volume":"177","author":"E Reitter","year":"2014","unstructured":"Reitter E, Ay C, Kaider A, Pirker R, Zielinski C, Zlabinger G, Pabinger I (2014) Interleukin levels and their potential association with venous thromboembolism and survival in cancer patients. Clin Experimental Immunol 177:253\u2013260","journal-title":"Clin Experimental Immunol"},{"key":"3342_CR143","doi-asserted-by":"publisher","first-page":"309","DOI":"10.1038\/s41577-021-00624-w","volume":"22","author":"H Baazim","year":"2022","unstructured":"Baazim H, Antonio-Herrera L, Bergthaler A (2022) The interplay of immunology and cachexia in infection and cancer. Nat Rev Immunol 22:309\u2013321","journal-title":"Nat Rev Immunol"},{"key":"3342_CR144","doi-asserted-by":"publisher","first-page":"9469","DOI":"10.3390\/ijms22179469","volume":"22","author":"AI Mart\u00edn","year":"2021","unstructured":"Mart\u00edn AI, Priego T, Moreno-Ruperez \u00c1, Gonz\u00e1lez-Hedstr\u00f6m D, Granado M, L\u00f3pez-Calder\u00f3n A (2021) IGF-1 and IGFBP-3 in inflammatory cachexia. Int J Mol Sci 22:9469","journal-title":"Int J Mol Sci"},{"key":"3342_CR145","first-page":"210","volume":"132","author":"S Chen","year":"2018","unstructured":"Chen S, Hu M, Shen M, Wang S, Wang C, Chen F, Tang Y, Wang X, Zeng H, Chen M (2018) IGF-1 facilitates thrombopoiesis primarily through Akt activation. Blood J Am Soc Hematol 132:210\u2013222","journal-title":"Blood J Am Soc Hematol"},{"key":"3342_CR146","doi-asserted-by":"publisher","first-page":"140","DOI":"10.3390\/ijms25010140","volume":"25","author":"IS Marques","year":"2023","unstructured":"Marques IS, Tavares V, Savva-Bordalo J, Rei M, Liz-Pimenta J, de Melo IG, Assis J, Pereira D, Medeiros R (2023) Long Non-Coding RNAs: Bridging Cancer-Associated Thrombosis and Clinical Outcome of Ovarian Cancer Patients. Int J Mol Sci 25:140","journal-title":"Int J Mol Sci"},{"key":"3342_CR147","doi-asserted-by":"publisher","first-page":"4072","DOI":"10.1167\/iovs.05-0105","volume":"46","author":"M Berdugo","year":"2005","unstructured":"Berdugo M, Andrieu-Soler C, Doat M, Courtois Y, BenEzra D, Behar-Cohen F (2005) Downregulation of IRS-1 expression causes inhibition of corneal angiogenesis. Investig Ophthalmol Vis Sci 46:4072\u20134078","journal-title":"Investig Ophthalmol Vis Sci"},{"key":"3342_CR148","doi-asserted-by":"publisher","first-page":"30","DOI":"10.1016\/j.jacc.2011.02.040","volume":"58","author":"DJ Angiolillo","year":"2011","unstructured":"Angiolillo DJ, Bernardo E, Zanoni M, Vivas D, Capranzano P, Malerba G, Capodanno D, Prandini P, Pasquali A, Trabetti E (2011) Impact of insulin receptor substrate-1 genotypes on platelet reactivity and cardiovascular outcomes in patients with type 2 diabetes mellitus and coronary artery disease. J Am Coll Cardiol 58:30\u201339","journal-title":"J Am Coll Cardiol"},{"key":"3342_CR149","unstructured":"Di Tano M (2019) Fasting-mimicking diet-based non-toxic combination therapy in cancer treatment: from molecules to bedside. https:\/\/air.unimi.it\/handle\/2434\/609110"},{"key":"3342_CR150","doi-asserted-by":"crossref","unstructured":"Margetis AT (2023) Caloric restriction for the management of malignant tumors\u2013from animal studies towards clinical translation","DOI":"10.1024\/0300-9831\/a000779"},{"key":"3342_CR151","doi-asserted-by":"crossref","unstructured":"Fanti M, Longo VD, Nutrition (2024) GH\/IGF-1 signaling, and cancer. Endocrine-related cancer 31","DOI":"10.1530\/ERC-23-0048"},{"key":"3342_CR152","doi-asserted-by":"publisher","first-page":"1634","DOI":"10.3390\/life15101634","volume":"15","author":"L Chen","year":"2025","unstructured":"Chen L, Shiao SL, Yuan Y (2025) Translating Metabolic Interventions into Breast Cancer Therapy: A Comprehensive Review. Life 15:1634","journal-title":"Life"}],"container-title":["Journal of Thrombosis and Thrombolysis"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s11239-026-03342-z.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s11239-026-03342-z","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s11239-026-03342-z.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,6,30]],"date-time":"2026-06-30T05:02:23Z","timestamp":1782795743000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s11239-026-03342-z"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,6,30]]},"references-count":152,"alternative-id":["3342"],"URL":"https:\/\/doi.org\/10.1007\/s11239-026-03342-z","relation":{},"ISSN":["1573-742X"],"issn-type":[{"value":"1573-742X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,6,30]]},"assertion":[{"value":"7 April 2026","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"9 June 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"30 June 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors declare no competing interests.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}]}}